コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 in 28 of them (1%); all tested negative for H7N9 virus.
2 minimise the risk of human infection with A H7N9 virus.
3 se traits were tested in the context of an A/H7N9 virus.
4 anges to the immunological properties of the H7N9 virus.
5 of human infection with an avian influenza A(H7N9) virus.
6 isease in China caused by avian influenza A (H7N9) virus.
7 n asymptomatic or mild human infections with H7N9 viruses.
8 ning replication potential of newly emerging H7N9 viruses.
9 ation, pathogenicity and transmissibility of H7N9 viruses.
10 iruses with genes derived from both H9N2 and H7N9 viruses.
11 ence of antigenically distinct LPAI and HPAI H7N9 viruses.
12 y to fuse at a lower pH threshold than other H7N9 viruses.
13 s HA from pandemic 1968 H3N2 and recent 2013 H7N9 viruses.
14 2013, which led to the zoonotic emergence of H7N9 viruses.
15 of mice infected with A(H5Nx), A(H6N1), or A(H7N9) viruses.
16 are essential for mammalian adaptation of A(H7N9) viruses.
17 essed the replication ability of three human H7N9 viruses (A/Anhui/1/2013, A/Shanghai/1/2013, A/Shang
18 ly, the NP of the newly emerged avian-origin H7N9 virus also contains an asparagine at position 52 an
19 ined the receptor-binding properties of this H7N9 virus and compared them with those of an avian H7N3
21 2013 was divergent from previously sequenced H7N9 viruses and more closely related to local circulati
22 A virus vaccination were able to neutralize H7N9 viruses and protect mice against homologous challen
23 magglutination-inhibiting antibodies against H7N9 viruses and protected mice from stringent viral cha
24 ity, and transmissibility of A/Anhui/1/2013 (H7N9) virus and variants in vitro and in vivo using a sy
32 hese findings suggest that the current human H7N9 viruses are poorly adapted for efficient human-to-h
34 uman infections with influenza A(H5N1) and A(H7N9) viruses are now annual seasonal occurrences in Asi
36 to the emergence of the A/Guangdong/1/2013 (H7N9) virus as a novel H7N9 virus in Guangdong, China, a
37 s of avian [A(H5N1), A(H5N6), A(H7N7), and A(H7N9) viruses associated with severe human disease] or s
38 jiang to other provinces and the presence of H7N9 viruses at live poultry markets have fuelled the re
41 lutination-inhibiting antibodies against the H7N9 virus, but we unexpectedly found high titers of ADC
43 ry changes at amino acid position 217 in the H7N9 viruses can serve as a genetic marker for virus ant
45 The hemagglutinin glycoprotein of most human H7N9 viruses carries Leu(226), a residue linked to adapt
46 thogenic avian H5N1 and the recently emerged H7N9 viruses cause severe infections in humans, often wi
48 18, the novel A/Anhui/1/2013 (AH/13)-lineage H7N9 virus caused at least five waves of outbreaks in hu
49 On 30 March 2013, a novel avian influenza A H7N9 virus causing severe human respiratory infections w
52 immunized animals.IMPORTANCE Avian influenza H7N9 viruses circulating in poultry and wild birds conti
54 g variation at the NA catalytic residue of A(H7N9) viruses, conferred reduced inhibition by laninamiv
57 entering the fourth wave of human infection, H7N9 viruses continue to exhibit genetic diversity in av
60 ons within the HA and PB2 genes of the novel H7N9 viruses created by reverse genetics in an important
63 etic studies have indicated that the novel A(H7N9) viruses emerged from reassortment of H7, N9, and H
64 mportance: The genomes of the zoonotic avian H7N9 viruses emerging in China have mutations in critica
66 Here, we found that, just prior to the fifth H7N9 virus epidemic, H9N2 viruses had phylogenetically m
68 Collectively, our results suggest that IAV(H7N9) viruses evolve in chickens through antigenic drift
69 These results also shed light on how the H7N9 virus evolved, which is critically important for fu
71 of Tc caprine with inactivated influenza A (H7N9) viruses followed by H7N9 Hemagglutinin 1 (HA1) boo
72 tant H1N1 and heterosubtypic H3N2, H5N1, and H7N9 viruses for at least 6 months while maintaining lun
73 prior to intranasal infection with H5N1 and H7N9 viruses for prophylaxis, and 24, 48, and 72 hours p
75 sequence of two chicken source influenza A (H7N9) viruses found in Guangdong live poultry market (LP
80 and PA genes in the generation of a dominant H7N9 virus genotype (G72) with enhanced infectivity in h
81 lating H7N9 virus to create a novel dominant H7N9 virus genotype that was responsible for the fifth H
86 e results suggest that the highly pathogenic H7N9 virus has pandemic potential and should be closely
87 cle, these results suggest that the emerging H7N9 virus has the potential both to transmit efficientl
88 rotein and virus that the NA of the zoonotic H7N9 viruses has a binding capacity via both the seconda
90 blic health, as the avian-origin influenza A(H7N9) virus has caused more than 1,560 laboratory-confir
92 c avian H5N1 virus and, more recently, avian H7N9 virus have resulted in high rates of lethality in h
94 hreat for poultry.IMPORTANCE Avian influenza H7N9 viruses have been causing disease outbreaks in poul
96 AI H7N9 viruses suggests that the fifth-wave H7N9 viruses have evolved to acquire novel traits with t
97 gether, we conclude that the fifth-wave HPAI H7N9 viruses have gained the ability to cause enhanced d
98 ution since their initial detection in 2013, H7N9 viruses have maintained a pathogenic phenotype in m
105 ) virus (A[H1N1]pdm09) and avian influenza A(H7N9) virus hemagglutinins (HAs) despite being seronegat
107 e of H9N2 virus in the continual mutation of H7N9 virus highlights the public health significance of
108 wing a pathway similar to that of the recent H7N9 virus, highlights the role of domestic ducks and th
109 es-were in clusters different from those for H7N9 viruses identified previously in other provinces of
110 have contributed to the spread of the novel H7N9 viruses.IMPORTANCE Novel H7N9 IAVs continue to caus
111 than 300 human infections with a novel avian H7N9 virus in China indicates that this emerging strain
113 e A/Guangdong/1/2013 (H7N9) virus as a novel H7N9 virus in Guangdong, China, and that viral adaptatio
114 tudy, we conducted enhanced surveillance for H7N9 virus in Guangdong, China, from April to August 201
115 ated and characterized the avian influenza A H7N9 virus in Guangdong, China, from April to August 201
116 chieve this, we propagated low-pathogenicity H7N9 virus in the presence of polyclonal antiserum deriv
117 We previously determined that propagation of H7N9 virus in virus-specific antiserum gives rise to mut
118 sette determines the transmission fitness of H7N9 viruses in chickens, and the reassortment events ca
119 structures of NAs from human-infecting avian H7N9 viruses in complex with five human anti-N9 antibodi
120 ight some distinctive properties of H5N1 and H7N9 viruses in different in vitro and in vivo models.
124 ere similarities between particular H5N1 and H7N9 viruses, including association between lethal disea
125 o acid changes on the evolutionary path to A(H7N9) viruses, including substitutions that may be assoc
128 healthy infants, children and adults against H7N9 virus-infected cells and recombinant hemagglutinin
133 ut all laboratory-confirmed human cases of A H7N9 virus infection reported in mainland China as of Fe
137 To provide insights into the pathogenesis of H7N9 virus infection, we compared risk factors, clinical
138 provide complete protection against group 2 H7N9 virus infection, while the variant loses protection
145 first identified cases of avian influenza A(H7N9) virus infection in humans occurred in China during
146 ver time, with identification of influenza A(H7N9) virus infections in humans, as well as detection o
148 Sequence analyses showed that the Guangdong H7N9 virus isolated from April to May shared high sequen
150 e relative virulence and transmissibility of H7N9 viruses isolated during the second and third waves,
152 e ability of first-, second-, and third-wave H7N9 viruses isolated from humans to cause disease in mi
155 ity of A/Anhui/1/2013 and A/Shanghai/1/2013 (H7N9) viruses, isolated from fatal human cases, to cause
156 w-pathogenic avian influenza (LPAI) and HPAI H7N9 virus isolates from the fifth epidemic wave were as
157 that a single mutation, L217Q, in the HA of H7N9 virus led to 23- and 8-fold reductions in hemagglut
159 n immunity to the emergent avian influenza A(H7N9) virus, neuraminidase inhibitors are vital for cont
161 vel highly pathogenic avian influenza (HPAI) H7N9 viruses of the fifth epidemic wave infect humans an
162 ng ensuing transmission events, the Anhui/13 H7N9 virus outcompeted 2:6 H7N9 AIVs with internal gene
164 ruses with pandemic potential, such as avian H7N9 virus, particularly against those carrying drug res
165 al distribution and genetic diversity of the H7N9 viruses poses a direct challenge to current disease
167 of human illnesses due to avian influenza A(H7N9) virus provided reason for US public health officia
168 n host; and (iii) both wild-type and variant H7N9 viruses rapidly develop additional mammalian-signat
173 Several high- and low-pathogenicity H7N3 and H7N9 viruses replicated efficiently in the respiratory t
177 esistant seasonal influenza A(H3N2) viruses, H7N9 virus replication and pathogenicity in these models
180 d deep sequencing analysis revealed that the H7N9 viruses sampled after transmission showed a reduced
184 ensure that current research with first-wave H7N9 viruses still pertains to more recently isolated st
185 study investigated the N9 NA from a zoonotic H7N9 virus strain in order to determine its possible rol
188 ty to fuse at a lower pH threshold than LPAI H7N9 viruses suggests that the fifth-wave H7N9 viruses h
190 tibodies against the antigenically drifted A(H7N9) viruses that emerged recently during the fifth-wav
191 ors revealed several amino acid changes in A(H7N9) viruses that may have facilitated transmission and
192 ion to genome segments derived from an avian H7N9 virus, the H7N3 virus reassorted efficiently with t
194 ur internal genes of the A/Guangdong/1/2013 (H7N9) virus-the NS, NP, PB1, and PB2 genes-were in clust
195 protects mice against lethal challenge with H7N9 virus through mechanisms likely involving antibody-
196 nces between the low- and high-pathogenicity H7N9 viruses, thus playing a major role in their antigen
197 Ferrets were then challenged with wild-type H7N9 virus to assess the vaccine's protective efficacy.
198 tations, were reassorted into co-circulating H7N9 virus to create a novel dominant H7N9 virus genotyp
199 inding assays, and ferret studies reveal the H7N9 virus to have increased binding to mammalian respir
200 n NP results in increased sensitivity of the H7N9 virus to human Mx, indicating that this residue is
201 itical mutations (i.e., HA-Q226L) enable the H7N9 viruses to be transmitted in a mammalian host and s
205 In this study, we assessed the ability of A(H7N9) virus to infect, replicate, and elicit innate immu
206 volutionary analysis of the progenitors of A(H7N9) viruses to identify amino acid changes that may ha
207 to assess the susceptibility of influenza A(H7N9) viruses to oseltamivir, the most prescribed anti-i
209 owever, limited, nonsustained human-to-human H7N9 virus transmission could not be ruled out in four f
211 have a confirmed case if the presence of the H7N9 virus was verified by means of real-time reverse-tr
212 ntial pandemic risk posed by avian influenza H7N9 viruses was heightened during the fifth epidemic wa
213 Among group 2 HA viruses tested, a single A(H7N9) virus was not neutralized at 50 mug/ml; it contain
214 6+2" reassortant H9N9 (having NP and NA from H7N9) virus was shed from contact chickens in a signific
216 be linked to the antigenic change among the H7N9 viruses, we serially passaged the viruses in the pr
217 ay also have contributed to the genesis of A(H7N9) viruses, we inferred historical evolutionary event
218 laboratory-confirmed human infections with A H7N9 virus were reported in mainland China, with 134 cas
223 Human infections with the avian influenza A(H7N9) virus were first reported in China in 2013 and con
224 ntly emerged A(H5N2), A(H5N8), A(H6N1), or A(H7N9) viruses were protected from mortality and showed d
226 in mice and ferrets than the low pathogenic H7N9 virus, with the exception of the neuraminidase inhi
227 013 was divergent from previously identified H7N9 viruses, with the NS and NP genes originating from